|
|
Article: Experimental therapy stops allergic reactions in mice.(Brief Article)
- Article from:
- Immunotherapy Weekly
- Article date:
- June 12, 2002
CopyrightCOPYRIGHT 2002 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Scientists supported by the National Institute of Allergy and Infectious Diseases (NIAID) have devised a new, experimental approach to treating allergic diseases. In mice, the scientists used a genetically engineered molecule to connect two receptors on the key immune system cells that cause allergic reactions.
Cross-linking these receptor molecules short-circuited the type of allergic reaction that leads to asthma, allergic rhinitis, and even the potentially deadly anaphylaxis caused by food allergy.
"This work represents an entirely new approach to treating allergic diseases," said NIAID Director Anthony S. ...